Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2006-09-05
2006-09-05
Seaman, D. Margaret (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C514S312000, C514S313000
Reexamination Certificate
active
07102007
ABSTRACT:
The present invention relates to novel dihydroindole and tetrahydroquinoline derivatives and pharmaceutically acceptable salts and/or pharmaceutically acceptable esters thereof. The compounds are useful for the treatment and/or prophylaxis of diseases which are associated with 2,3-oxidosqualene-lanosterol cyclase such as hypercholesterolemia, hyperlipemia, arteriosclerosis, vascular diseases, mycoses, gallstones, tumors and/or hyperproliferative disorders, and treatment and/or prophylaxis of impaired glucose tolerance and diabetes.
REFERENCES:
patent: 3997542 (1976-12-01), Bailey
patent: 0 318 860 (1989-06-01), None
patent: 636 367 (1995-02-01), None
patent: WO 93 12754 (1993-07-01), None
patent: WO 97 28128 (1997-08-01), None
patent: WO 99 00371 (1999-01-01), None
patent: WO 01 87834 (2001-11-01), None
Gotto et al., Circulation 81, pp. 1721-1733 (1990).
Stein et al., Nutr. Metab. Cardiovasc. Dis. 2, pp. 113-156 (1992).
Illingworth, Med. Clin. North Am. 84, pp. 23-42 (2000).
Ross et al., Arch. Intern. Med. 159, pp. 1793-1802 (1999).
Ellen et al., J. Cardiol. 81, pp. 60B-65B (1998).
Shepherd, Eur. Heart J. 16, pp. 5-13 (1995).
Davignon et al., Can. J. Cardiol 8, pp. 843-864 (1992).
Pedersen et al., Drug Safety 14, pp. 11-24 (1996).
Morand et al., J. Lipid Research 38, pp. 373-390 (1997).
Mark et al., J. Lipid Research 37, pp. 148-158 (1996).
Peffley et al., Biochem. Pharmacol 56, pp. 439-449 (1998).
Nelson et al., J. Biol. Chem. 256, pp. 1067-1068 (1981).
Spencer et al., J. Biol. Chem. 260, pp. 13391-13394 (1985).
Panini et al., J. Lipid Research 27, pp. 1190-1204 (1986).
Ness et al., Arch. Biochem. Biophys. 308, pp. 420-425 (1994).
Janowski et al., Proc. Natl. Acad. Sci. USA 96, pp. 266-271 (1999).
Venkateswaran et al., J. Biol. Chem. 275, pp. 14700-14707 (2000).
Costet et al., J. Biol. Chem. 275, pp. 28240-28245 (2000).
Ordovas et al., Nutr. Rev. 58, pp. 76-79 (2000).
Schmitz et al., Front. Biosci 6, D505-D514 (2001).
Tobin et al., Mol. Endocrinol. 14, pp. 741-752 (2000).
Marshall et al., J. Org. Chem. 61(17), pp. 5729-5735 (1996).
Baker et al., J. Chem. Soc. Perkin Trans. 1, pp. 1415-1421 (1990).
Belostotskii et al., Tetrahedron Letters 35(28), pp. 5075-5076 (1994).
Bartlett et al., J. Am. Chem. soc. 106(25), pp. 7854-7860 (1984).
Cooper et al., Synthesis (4), pp. 621-625 (2001).
Stara et al., Collect. Czech. Chem. Commun. 64(4), pp. 649-672 (1999).
Ackermann Jean
Aebi Johannes
Chucholowski Alexander
Dehmlow Henrietta
Morand Olivier
Hoffmann-La Roche Inc.
Johnston George W.
Parise John P.
Seaman D. Margaret
LandOfFree
Dihydroindole and tetrahydroquinoline derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Dihydroindole and tetrahydroquinoline derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Dihydroindole and tetrahydroquinoline derivatives will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3565490